Target intelligence / Profile preview

Beta-adrenoceptor and Alpha1-adrenoceptor (β1-AR and α1-AR)

Target
β1-AR and α1-AR
Molecular classification
G protein-coupled receptor (GPCR), Receptor
01

Overview

Beta-adrenergic receptor and Alpha-1 adrenergic receptor are subclasses of adrenergic receptors—G protein-coupled receptors that mediate the physiological effects of the catecholamines norepinephrine and epinephrine. Beta-1 adrenergic receptors are primarily expressed in the heart and kidneys and are key regulators of heart rate, myocardial contractility, and renin release. Alpha-1 adrenergic receptors, found mostly on smooth muscle of blood vessels and organs, drive vasoconstriction and blood pressure regulation, and also participate in other smooth muscle contractions throughout the body. Both receptor families are major drug targets in cardiovascular, neurological, and certain metabolic diseases, with well-established agonists and antagonists used therapeutically.

Other names
Beta-adrenergic receptorβ-adrenergic receptorbeta-adrenoceptorbeta-ARBeta-1 adrenergic receptorβ1-adrenoceptorAlpha-1 adrenergic receptorα1-adrenoceptoralpha-1 ARAdrenergic receptorAdrenoceptor
02

Mechanism of action

β1-AR: Agonists: Increase heart rate, contractility, conduction velocity via Gs and cAMP signaling. Antagonists: Decrease heart rate, blood pressure; block catecholamine effects (used in hypertension, arrhythmia, etc.). α1-AR: Agonists: Vasoconstriction by activating Gq, IP₃/DAG pathway, increasing intracellular calcium. Antagonists: Vasodilation, reduced blood pressure; relax smooth muscle in bladder/prostate.

03

Biological functions

Signal transduction (via catecholamines: norepinephrine, epinephrine)Regulation of heart rate and contractilitySmooth muscle contraction/vasoconstrictionRegulation of blood pressure and vascular toneRenin releasecardiac hypertrophyneurotransmissionsynaptic plasticity
04

Disease associations

Cardiovascular disease (hypertension, heart failure, arrhythmia, coronary artery disease)MigraineGlaucomaShockanaphylaxisNeurodegenerative diseaseInflammationStress/fight-or-flight response
05

Safety considerations

β1-AR antagonists: Bradycardia, heart block, hypotension, bronchospasm (with non-selective agents)β1-AR agonists: Arrhythmia, increased oxygen demand, cardiac ischemiaα1-AR antagonists: Orthostatic hypotension, syncope, dizzinessAgonists (α1-AR): Hypertension, reflex bradycardia, urinary retention
06

Interacting drugs

Dobutamine

12 more in the full profile.

07

Biomarkers

blood pressureheart ratecatecholamine levelsexpression levelsBlood pressure responseHeart rate changes

Beyond the preview

Go deeper on Beta-adrenoceptor and Alpha1-adrenoceptor (β1-AR and α1-AR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-adrenoceptor and Alpha1-adrenoceptor (β1-AR and α1-AR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call